top of page
#WCIRDC24
CME Conference on December 12-14, 2024
Hilton Universal Hotel Los Angeles
555 Universal Hollywood Dr, Universal City, CA 91608
Virtual Poster Hall
21st WCIRDC
Accepted Abstracts 2023
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
Congratulations to the Top 6 Abstracts.
#0023, #0035, #0044, #0071, #0077, #0088
the Oral Abstract Booklet.
#0001
Pancreatic Shear Wave Elastography in Children and Adolescents with Type 1 Diabetes; Relation to Pancreatic Residue
Author/s:
Nouran Yousef Salah1, Sherihane Said Madkour2, Khaled Sayed Soliman2
Organizations/Affiliations:
Ain Shams University
Main Contact Person's Name:
Nouran Salah
Main Contact Person's E-Mail
nouranyousef@med.asu.edu.eg
#0003
The Function and Roles of ADAMTS-7 in Experimental Diabetic Cardiomyopathy
Author/s:
Nihat Yumusak*, DVM, PhD,*, Associate Professor of the Department of Pathology, Veterinary Medical Faculty of Harran University, Akin Yigin, DVM, PhD,*, Associate Professor of the Department of Genetics, Veterinary Medical Faculty of Harran University
Organizations/Affiliations:
Harran University, 63100, Sanliurfa, Turkey
Main Contact Person's Name:
Nihat Yumusak
Main Contact Person's E-Mail:
nihatyumusak@harran.edu.tr
#0004
Prevalence of kidney and Hepatic Dysfunction, and Outcomes in Hospitalized Patients With COVID-19 Infection in SBA region (west of Algeria)
Author/s:
Demmouche Abbassia*, Abdallah Touati Djihène, Bouazza Sofiane ; Belmous Asmaa ; Bekhadda Hadjer : Itatahine Amina ; Mai Hicham
Organizations/Affiliations:
Biotoxicology laboratory, Department of Biology, Faculty of Natural Sciences and life-Djillali Liabes University of Sidi Bel Abbes, Algeria
Main Contact Person's Name:
DEMMOUCHE Abbassia
Main Contact Person's E-Mail:
demmoucheabbassia@yahoo.fr
#0005
Semaglutide and lanifibranor Differentially Alter NASH and Liver Fibrosis in Diet-Induced Obese Hamsters With or Without Free Access to Alcohol
Author/s:
Francois Briand, Ph.D, Estelle Grasset, Ph.D, Natalia Breyner, Ph.D, Thierry Sulpice, Ph.D
Organizations/Affiliations:
PHYSIOGENEX
Main Contact Person's Name:
FRANCOIS BRIAND
Main Contact Person's E-Mail
f.briand@physiogenex.com
#0006
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort.
Author/s:
Noraidatulakma Abdullah,PhD, Senior Lecturer, Goh Ying Xian, MSc, Research Officer, Aisyatul Najihah Khuzaimi, Bsc, Research Officer, Azwa Shawani Kamalul Arifin, BSc, Science Officer, Nurul Ain Mhd Yusuf, MSc, Science Officer, Nazihah Abd Jalal, BSc, Science Officer, Norliza Ismail, BSc, Science Officer, Nurul Faeizah Husin, MSc, IT Officer, Rahman Jamal, PhD, MD, Professor.
Organizations/Affiliations:
Universiti Kebangsaan Malaysia Medical Molecular Biology Institute (UMBI)
Main Contact Person's Name:
Noraidatulakma Abdullah
Main Contact Person's E-Mail:
noraidatulakma.abdullah@ppukm.ukm.edu.my
#0007
Microbial Metabolite UDP-Galactose Restores Islet β-cell Function in Mice via the Gut–Islet Axis
Author/s:
Feng Zhang, PhD
Organizations/Affiliations:
Affiliated Hospital of Jiangnan University
Main Contact Person's Name
Feng Zhang
Main Contact Person's E-Mail:
fengzhang@jiangnan.edu.cn
#0008
Humanistic and Economic Burden of Patients With Cardiorenal Metabolic (CRM) Conditions: A Systematic Literature Review
Author(S): 1. Keith C. Ferdinand, MD; 2. Keith C. Norris, MD PhD; 3. Helena W. Rodbard, MD; 4. Jennifer M. Trujillo, PharmD
Organization/Affiliation:
1. Tulane University School of Medicine, Cardiology Section, New Orleans, LA; 2. Department of Medicine, Division of General Internal Medicine and Health Services Research, University of California, Los Angeles, Los Angeles, CA; 3. Endocrine and Metabolic Consultants, Rockville, MD; 4. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, CO
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0009
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon,
GLP-1 & GIP Receptors
Author(S): 1. W. Timothy Garvey, MD; 2. Cathy D. Mahle, PhD; 3. Robert F. Kushner, MD
Organization/Affiliation
1. University of Alabama at Birmingham, Birmingham, AL, USA; 2. Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA; 3. Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0010
Biochemical Investigation Of Genetic Polymorphism Of Mthfr (C677t) Rs 1801133 With Myocardial Infarction
Author/s:
Muhammad Sajid Hamid Akash1, Momina Shahid2, Kanwal Rehman2, Tauqeer Hussain Mallhi4, Yusra Habib Khan4
Organizations/Affiliations:
1Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan. 2Department of Pharmacy, The University of Faisalabad, Faisalabad, Pakistan. 3Department of Pharmacy, The Women University, Multan, Pakistan. 4Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0011
Biochemical Association Of Genetic Mutation Of Klf14 Rs4731702 With Risk Factors Of Diabetes Mellitus
Author/s:
Muhammad Sajid Hamid Akash1, Sumbal Rasheed1, Kanwal Rehman2, Tauqeer Hussain Mallhi3, Yusra Habib Khan3
Organizations/Affiliations:
1Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan. 2Department of Pharmacy, The Women University, Multan, Pakistan. 3Department of Clinical Pharmacy, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0013
Levels of Biomarkers of Fibrosis in Patients with Diabetes Mellitus Type 2
Author(S): K.Tchaava, N.Gegeshidze, N.Ninashvili, T.Giorgadze, N.Kilasonia
Organization/Affiliation:
Tbilisi State Medical University, Georgian Technical University, Georgia
Organization/Affiliation
Tbilisi State Medical University, Georgian Technical University, Georgia
Main Contact Person's Name:
Khatuna Tchaava
Main Contact Person's E-Mail:
khatuna_chaava@mail.ru
#0015
Risk of Obesity, Diabetes, Insulin Resistance, and Dyslipidemia Among Irritable Bowel Syndrome Patients.
Author(S): Yomna E. Dean 1, Jose Jonathan Loayza Pintado 2, Lucy L. Nale 3, Samah S. Rouzan 1, Ahmed Abbas 4, Mohamed Doma 1, Abdulla M. Aboushaira 1, Farah Alkasajy 5, Ahmed A. Ghanem 6, Vinayak Mahesh Patil 7, Yana Gordeyeva 8, Karam R. Motawea 1, Masako Lien Le 8, Adham Galal 1, Laura Cicani 9, Raneem Mohamed Atta 1, Sameh Samir Elawady 10, Lamya Alzabidi 11, Ahmed Soliman 12, Tamer Mady 13, Hani Aiash 14
Organization/Affiliation:
1: Alexandria University 2: Universidad de San Martín de Porres 3: Windsor University School of Medicine 4: Zagazig university 5: Hashemite University 6: Mansoura University 7: Karnataka Institute of Medical Sciences 8: Poznan University of Medical Sciences 9: International University of Health Sciences 10: Neuro-endovascular Surgery Department, Medical University of South Carolina (MUSC) 11: Faculty of Medicine and Health Sciences, Sanaa University 12: Ain Shams University 13: International American University College of Medicine 14: SUNY Upstate Medical University
Main Contact Person's Name:
Yomna E. Dean
Main Contact Person's E-Mail:
Yomnadean@gmail.com
#0017
Influence of Lipid Profile on the Risk of Carcinoma Breast in North Indian Women
Author/s:
*Dr Snehal Sawant, Senior Resident ,Department of Biochemistry Dr Anita Rani ,Director -Professor Department of Biochemistry Dr S. V. Arya Consultant, Professor and Head of Unit , Department of Surgery , ** Dr Prabhpreet Bhogal, GDMO Emergency Medicine
Organizations/Affiliations:
*Vardhman Mahavir Medical college & Safdarjung Hospital New Delhi, **Delhi Cantonement General Hospital New delhi
Main Contact Person's Name:
Dr. Snehal Sawant
Main Contact Person's E-Mail:
dr.snehal007@gmail.com
#0018
Low Muscle Strength as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Different Metabolic Subgroups
Author(S):
Hye-Sun Rho, Whan-Seok Choi
Organization/Affiliation:
Department of Family Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Main Contact Person's Name:
Hye-Sun Rho
Main Contact Person's E-Mail:
hyesunnote@gmail.com
#0019
Association of Serum Vitamin D Level and Type 2 Diabetes with Nonalcoholic Fatty Liver Disease
Author/s:
Maosheng Lee1,2, Siping Peng1,2, Xiaohui Xiao2, Zengying Li1,2, Hengxia Zhao1,2, Huilin Li1,2*
Organizations/Affiliations:
The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine
Main Contact Person's Name:
Maosheng Lee
Main Contact Person's E-Mail:
realsmile365@163.com
#0020
The Relationship Between Vitamin D level and Sarcopenia : Insights from a Korean Population Study
Author/s:
Shinyoung Roh, M.D., Kyung-Soo Kim, M.D.
Organizations/Affiliations:
Department of Family Medicine, Seoul St. Mary's Hospital, The Catholic University Medical Center of Korea
Main Contact Person's Name:
Shinyoung Roh, M.D.
Main Contact Person's E-Mail:
1brilliant@naver.com
#0022
Maternal Dehydration Contributes to the Development of Salt Sensitivity of Blood Pressure (SSBP) in Offspring, with its Influence Likely Tied to an Elevation in Vasopressin Secretion.
Author(S):
Kim Y-B, PhD, Jung WW, PhD, Jin X, MD, PhD., Kang HK, MS, Kim YI, PhD
Organization/Affiliation:
Department of Physiology and Neuroscience Research Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea
Main Contact Person's Name:
Yang In Kim
Main Contact Person's E-Mail:
yikim@korea.ac.kr
#0023
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity
Author(S):
1. M Carel W Le Roux, BChB, MSC, FRCP, FRCPath, PhD; 2. Oren Steen, MD, FRCPC; 3. Kathryn J Lucas, MD; 4. Elena Startseva, MD, MBA; 5. Luiza Borowska MD; 6. Anna Unseld, Dipl Stat
Organization/Affiliation:
1. School of Medicine, St. Vincent's University Hospital and University College Dublin, Dublin, Ireland; 2. LMC Diabetes & Endocrinology, Toronto, Ontario, Canada; 3. Diabetes & Endocrinology Consultants PC, Morehead City, NC, USA; 4. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 5. Boehringer Ingelheim International GmbH, Ingelheim, Germany; 6. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany
Main Contact Person's Name:
Paul Lidbury
Main Contact Person's E-Mail:
paul.lidbury@envisionpharma.com
#0025
Improving Health Care Staff Knowledge on Women’s Heart Health Through a Multi-Layered Approach
Author/s:
Nazli Parast; Thais Coutinho; Amelie Paquin; Bonnie Quinlan; Amy Charlebois; Kara Murfitt; Heather Tulloch; Stephanie LEBLANC; Tammy Lafreniere; Helena Van Ryn; Deborah Younger-Lewis; Sandra Wong; Bonnie Bowes; Lindsay MacArthur
Organizations/Affiliations:
University of Ottawa Heart Institute
Main Contact Person's Name:
Nazli Parast
Main Contact Person's E-Mail:
naparast@ottawaheart.ca
#0026
Evaluating Cross Talk Between Insulin Resistance, Inflammation And Fibrosis Along With Exploring Therapeutic Potential Of Beta Vulgaris In Experimentally Induced Diabetic Cardiomyopathy In Rat Model
Author/s:
Laaraib Nawaz (PhD scholar), Ayesha Saddiqa (MPhil scholar), Haseeb Anwar (Associate Professor)
Organizations/Affiliations:
Health Biology Laboratory, Department of Physiology, Faculty of Life Sciences,Government College University Faisalabad 38000 Punjab Pakistan
Main Contact Person's Name:
Dr. Haseeb Anwar
Main Contact Person's E-Mail:
drhaseebanwar@gcuf.edu.pk
#0033
NP 0033 Profiling Of Putative Mirnas (8-Mer) Against The T2DM And MI Associated Genes
Author/s:
Khadam Hussain, Ayesha Ishtiaq, Iram Murtaza*
Organizations/Affiliations:
, Signal Transduction Laboratory, Department of Biochemistry, Quaid i Azam University, Islamabad, 45320, Pakistan
Main Contact Person's Name:
Iram Murtaza
Main Contact Person's E-Mail:
irambch@qau.edu.pk
#0034
The Association Of Insulin Resistance And Mild Cognitive Impairment In Elderly Patients With Alzheimer's Disease
Author/s:
Yethindra Vityala1; Tugolbai Tagaev2; Sai Kiran Ramanujam3; Immi Harshitha Kalapala4; Afreen Begum Kaggallu5; Sameena Sultana4; Gowtham Devara4; Altynai Zhumabekova2; Krishna Priya Kanteti3; Ujwala Damineni6
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre Mangalore, Karnataka, India; 2I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan; 3Gandhi Medical College and Hospital, Secunderabad, Telangana, India; 4Siddhartha Medical College, Vijayawada, Andhra Pradesh, India; 5Vijayanagar Institute of Medical Sciences, Ballari, Karnataka, India, 6Maheshwara Medical College and Hospital, Hyderabad, Telangana, India
Main Contact Person's Name:
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0035
Reduced Lipotoxicity Following Triple Therapy for 3 Years in New Onset T2DM
Author/s:
Olga Lavynenko, MD, PhD, Muhammad Abdul-Ghani, MD, PhD, and Ralph A. DeFronzo, MD
Organizations/Affiliations:
Division of Endocrinology, Diabetes, & Metabolism, Beth Israel Deaconess Medical Center, Boston, MA and Diabetes Division UT Health & Texas Diabetes Institute, San Antonio, Tx
Main Contact Person's Name:
Olga Lavrynenko
Main Contact Person's E-Mail:
olgalavrynenko@gmail.com
#0036
Exploring The Role Of Insulin Resistance In Neurodegenerative Disorders: Insights From Clinical And Neuroimaging Analysis
Author/s:
Komal Jabeen1,2, Kanwal Rehman3, Muhammad Sajid Hamid Akash4
Organizations/Affiliations:
1Institute of Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan. 2Department of Pharmacy, Niazi Medical and Dental College, Sargodha 40100, Pakistan 3Department of Pharmacy, The Women University, Multan, Pakistan. 4Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.
Main Contact Person's Name:
Muhammad Sajid Hamid Akash
Main Contact Person's E-Mail:
sajidakash@gcuf.edu.pk
#0037
Comparison of Glucose and Insulin Profile Between Normal and Prediabetic Subjects
Author/s:
Ava S Kumar*, Joseph W Babiarz
Organizations/Affiliations:
Aspirus Wausau Hospital, Wausau, WI, *DC Everest High School, Weston, WI
Main Contact Person's Name:
Ava S Kumar
Main Contact Person's E-Mail:
avakumar@icloud.com
#0040
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016
Author/s:
Jaedong LEE, M.D, Fellow
Organizations/Affiliations:
Department of Family Medicine, Eunpyeong ST. Mary's Hospital, Seoul, Korea
Main Contact Person's Name:
Jaedong LEE
Main Contact Person's E-Mail:
drleejd@gmail.com
#0041
Relationship Between Interleukin-6 -174 G/C Gene With IL-6 Level And Insulin Resistance In Adult Polycystic Ovary Syndrome Women
Author/s:
Abhishek Gupta, MSc, PGDBI, PhD and Vani Gupta, MBBS, MD, DNB, MNAMS
Organizations/Affiliations:
Department of Physiology, King George's Medical University, Lucknow-226003, UP, India
Main Contact Person's Name:
Dr. Abhishek Gupta
Main Contact Person's E-Mail:
abhikgmu@gmail.com
#0044
Carbohydrate Restriction-Induced Elevations In LDL-Cholesterol And Atherosclerosis: The KETO Trial
Author/s:
Matthew Budoff1, Venkat S. Manubolu1, April Kinninger1, Nicholas G. Norwitz2, David Feldman3, Thomas R. Wood4, Ricardo Cury5, Theodore Feldman5, Jonathan Fialkow5, Khurram Nasir6 1 Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, United States 2 Harvard Medical School Boston, MA, United States 3 Citizen Science Foundation, Las Vegas, Nevada 4 Department of Pediatrics, University of Washington School of Medicine, Seattle, WA 98195, USA 5 Miami Cardiac and Vascular Institute, Baptist Health South Florida, Miami, FL, United States 6 Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States
Organizations/Affiliations:
Lundquist Institute at Harbor UCLA
Main Contact Person's Name:
Matthew Budoff
Main Contact Person's E-Mail:
mbudoff@lundquist.org
#0045
Associations Of Single Nucleotide Variants Of The FTO Gene With Metabolic Disorders In Children With Obesity
Author/s:
Aleksandr Abaturov, Anna Nikulina, Dmytro Nikulin
Organizations/Affiliations:
Dnipro State Medical University
Main Contact Person's Name:
Dmytro Nikulin
Main Contact Person's E-Mail:
dn0327481@gmail.com
#0046
Defining Cardio-renal-metabolic (CRM) Syndrome: A Targeted Literature Review
Author/s:
Brendan Clark, PharmD, MS (a), Mary Mulrooney, PharmD, MBA (b), Benjamin Miao, PharmD (a), Dheeraj Kataria, MPharma (b), Aishwarya Kulkarni, MS (b), Jeffrey R. Skaar, PhD (b)
Organizations/Affiliations:
(a) Boehringer Ingelheim Pharmaceuticals, Inc. (b) Trinity Life Sciences
Main Contact Person's Name
Brendan Clark
Main Contact Person's E-Mail:
brendan.clark@boehringer-ingelheim.com
#0047
Effect of empagliflozin on all-cause hospitalization in EMPA-KIDNEY
Author/s:
Anastasia Uster MD,1 Nihar Desai MD,2 Sankar D Navaneethan MD,3 Egon Pfarr MSc,1 Anna Rita Mazo MD1
Organizations/Affiliations:
1) Boehringer Ingelheim International GmbH, Ingelheim-am-Rhein, Germany 2) Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA 3) Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Main Contact Person's Name:
Anastasia Uster
Main Contact Person's E-Mail:
anastasia.uster@boehringer-ingelheim.com
#0048
Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial
Author(S):
Yunqi Wu, M.M., Li Zhang, M.B., Haizhen Sun, M.D., Guangyang Ma, M.D., Ph.D, Shan Lu, M.D., Saijun Zhou, M.D., Pei Yu, M.D.
Organization/Affiliation:
1.NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China 2.Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University,Tianjin 300134, China
Main Contact Person's Name:
Yunqi Wu
Main Contact Person's E-Mail:
wyq67206@163.com
#0049
Visceral, Subcutaneous Fat And Bone Mineral Density Distribution In People With Cardiometabolic Risk Factors.
Author/s:
Adriana Janet Segura Saldaña1, RD; Diego Emiliano Chávez Fernández1, RD; Baldomero Morales Campos1, RD, MSc; Eliud Salvador Aguilar Barrera1,2, RD, MSc.
Organizations/Affiliations:
1Posgraduate Department, CICS-UMA, Instituto Politécnico Nacional. Mexico City, Mexico. 2Asociacion Mexicana para el Estudio de la Diabetes y sus Complicaciones, Mexico City, Mexico.
Main Contact Person's Name:
Eliud Salvador Aguilar Barrera
Main Contact Person's E-Mail:
aguilarbarrerae@gmail.com
#0050
The Role Of Vortex Flow Analysis By Contrast Echocardiography To Predict Clinical Outcome In Heart Failure With Reduced Ejection Fraction
Author/s:
In-Cheol Kim1, Se-In Park1*, Hye-Su Yun1, Gianni Pedrizzetti2, Geu-Ru Hong3
Organizations/Affiliations:
Keimyung University Dongsan Hospital, Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Daegu, Korea (Republic of)
Main Contact Person's Name:
In-Cheol Kim
Main Contact Person's E-Mail:
aupfe80@gmail.com
#0051
Elucidating The Diagnostic Potential Of Mirna In Coronary Artery Disease By Identifying Transcription Level Variations In Patients
Author/s:
Wishma Seher, Ayesha Ishtiaq, Iram Murtaza
Organizations/Affiliations:
Signal Transduction Laboratory, Quaid-i-Azam University, Islamabad, Pakistan
Main Contact Person's Name:
Ayesha Ishtiaq
Main Contact Person's E-Mail:
ayesha@bs.qau.edu.pk
#0052
C3ar1 On Beta Cells Preserves Beta Cell Function And Glucose Homeostasis In Diabetic Mice By Decreasing Metabolic Stress And Dedifferentiation
Author/s:
Renan Lima PhD, Ankit Gilani PhD, Lisa Stoll PhD, Eric Cortada PhD, Edwin Homan MD, PhD, Kou Ang Li, Deanndria Singleton, Tint Tha Ra Wun, James C. Lo MD, PhD
Organizations/Affiliations:
Weill Center for Metabolic Health, Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Main Contact Person's Name:
Renan Pereira de Lima
Main Contact Person's E-Mail:
rpl4002@med.cornell.edu
#0053
Relationship Between Obesity Indices measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men
Author/s:
Salie Lee, MD, Bassam Yaghmour, MD, Soshin Kye, MD
Organizations/Affiliations:
Salie Lee, MD, Research Scholar, Division of Pulmonary and Critical Care, UC Irvine Bassam Yaghmour, MD, Associate Professor, Division of Pulmonary and Critical Care, UC Irvine Soshin Kye*, MD, Head of the Department of Family Medicine, National Police Hospital, Republic of Korea
Main Contact Person's Name
Salie Lee
Main Contact Person's E-Mail:
saliel@hs.uci.edu
#0054
Contribution Of SNV GLP1R In Diseasome Of Metabolically Unhealthy Obesity
Author/s:
Aleksandr Abaturov, Anna Nikulina, Dmytro Nikulin, Anastasiia Holikova, Daryna Dikhtyarenko
Organizations/Affiliations:
Dnipro State Medical University
Main Contact Person's Name:
Dmytro Nikulin
Main Contact Person's E-Mail:
dn0327481@gmail.com
#0055
Effect Of Diet On Insulin Resistance In Adults At Risk Of Developing Type 2 Diabetes Mellitus
Author/s:
Yethindra Vityala1; Rithwik Goud Burri2; Krishna Chaitanya Meduri2; Sai Praneeth Duvvuri2; Sriharsha Lankala2; Annie Monica Ch2; Raghu Ram Shanmukh Nemani3; Tejaswi Vadde4; Sai Prasad Karuturi4; Harish Kumar Jella4
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre Mangalore, Karnataka, India; 2Maheshwara Medical College and Hospital, Hyderabad, Telangana, India; 3GSL Medical College and General Hospital, Rajahmundry, Andhra Pradesh, India; 4SVS Medical College, Mahbubnagar, Telangana, India
Main Contact Person's Name:
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0057
0057 Effect of Finerenone on the Incidence of Hypokalemia in Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Author/s:
Bertram Pitt, MD,1; Rajiv Agarwal, MD,2; Stefan D. Anker, MD,3; George L. Bakris, MD,4; Peter Rossing, MD,5,6; Luis Ruilope, MD,7-9; Charles A. Herzog, MD,10; Barry H. Greenberg, MD,11; Robert Pecoits-Filho, MD,12,13; Faiez Zannad, MD,14; Marc Lambelet, Dipl Math,15; Robert Lawatscheck, MD,16; Andrea Scalise, MD,17; Gerasimos Filippatos, MD,18; Asia Quan, PharmD,19; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, University of Michigan School of Medicine Ann Arbor, MI, USA; 2. Indiana University School of Medicine and Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA; 3. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité–Universitätsmedizin, Berlin, Germany; 4. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 5. Steno Diabetes Center Copenhagen, Herlev, Denmark; 6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 7. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 8. CIBERCV, Hospital Universitario 12 de Octubre, Madrid, Spain; 9. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 10. Cardiology Division, Department of Internal Medicine, Hennepin Healthcare/University of Minnesota, Minneapolis, MN, USA; 11. University of California San Diego, La Jolla, CA, USA; 12. Arbor Research Collaborative for Health, Ann Arbor, MI, USA; 13. School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; 14. Henri Poincaré University, Nancy, France; 15. Chrestos Concept GmbH & Co. KG, Essen, Germany; 16. Cardiology and Nephrology Clinical Development, Bayer AG, Berlin, Germany; 17. Pharmaceutical Development, Bayer Hispania S.L., Barcelona, Spain; 18. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 19. Bayer US LLC, Whippany, NJ, USA
Main Contact Person's Name:
Asia Quan
Main Contact Person's E-Mail:
asia.quan@bayer.com
#0058
Effect of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Baseline Anemia Status: A FIDELITY Analysis
Author/s:
Ajay Singh, MBBS,1; Stefan D. Anker, MD,2,3; Gerasimos Filippatos, MD,4; Bertram Pitt, MD,5; Peter Rossing, MD,6,7; Luis M. Ruilope, MD,8-10; Alfredo E. Farjat, PhD,11; Glen James, PhD,12; Youssef M.K. Farag, MD,PhD,13; Luke Roberts, MBBS PhD,14; George L. Bakris, MD,15; Tram Knecht, PharmD,13; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Renal Division, Harvard Medical School, Harvard University, Boston, MA, USA; 2. Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany;3. Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland; 4. National and Kapodistrian University of Athens, School of Medicine, Department of Cardiology, Attikon University Hospital, Athens, Greece; 5. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 6. Steno Diabetes Center Copenhagen, Herlev, Denmark; 7. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 8. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 9. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 10. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 11. Research and Development, Clinical Data Sciences and Analytics, Bayer PLC, Reading, UK; 12. Integrated Evidence Generation and Business Innovation, Bayer PLC, Reading, UK; 13. Cardiovascular and Renal United States Medical Affairs, Bayer U.S. LLC, Whippany, NJ, USA; 14. Clinical Development, Bayer PLC, Reading, UK; 15. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA
Main Contact Person's Name:
Tram Knecht
Main Contact Person's E-Mail:
tram.knecht@bayer.com
#0059
Empagliflozin Reduces Liver Fat in Diabetic and Nondiabetic Subjects
Author/s:
Siham Abdelgani MD, Ahmed Khattab MD, John Adams MD, Gozde Baskoy MD, Marissa Brown PhD, Geoff Clarke PhD, Olga Larvenenko, MD, PhD, Ralph A DeFronzo MD, Muhammad Abdul-Ghani MD, PhD
Organizations/Affiliations:
UTH San Antonio
Main Contact Person's Name:
Siham Abdelgani
Main Contact Person's E-Mail
Abdelgani@uthscsa.edu
#0060
Pathophysiology of Insulin Resistance: Connecting the Dots
Author(S):
Suresh N. Shinde,MD.
Organization/Affiliation:
Academy of Continuing Medical Education & research, Pune,India; Poona Hospital & Research Centre, Pune, India
Main Contact Person's Name:
Dr Suresh N Shinde
Main Contact Person's E-Mail:
acmepune@yahoo.com
#0061
Prevalence And Clinical Characteristics Of Patients With Transthyretin Amyloidosis In The United States And Japan: Results From The Overtture Study
Author/s:
Jason Wright (Pharm.D.), Christian S. Alvarez (Ph.D.), Lai San Hong (Ph.D.), Krister Järbrink (Ph.D.), Neela Kumar(Ph.D.), Christina Pao (Ph.D.), Eric Wittbrodt (Pharm.D.), Shun Kohsaka (M.D.)
Organizations/Affiliations:
AstraZeneca
Main Contact Person's Name:
Christian S. Alvarez
Main Contact Person's E-Mail:
christian.alvarez@astrazeneca.com
#0063
Sotagliflozin Significantly Reduces CV Death and Heart Failure-related Outcomes in Patients with Type 2 Diabetes, Chronic Kidney Disease, and History of Heart Failure
Author/s:
*MB Hardin, PharmD; *AK Carroll, PhD; *MJ Davies, PhD; *M Girard, MS; *P Banks, MS; **B Pitt, MD; ***PG Steg, MD; ****DL Bhatt, MD, MPH
Organizations/Affiliations:
*Lexicon Pharmaceuticals, The Woodlands, TX; **University of Michigan, Ann Arbor, MI; AP-HP, ***Hôpital Bichat, Paris, France; ****Mount Sinai Heart, New York, NY
Main Contact Person's Name:
Belinda Hardin
Main Contact Person's E-Mail
bhardin@lexpharma.com
#0064
Relationship Between Myeloperoxidase And Metabolic Syndrome At Older Patients
Author/s:
Gianina Ioana Constantin1, Simona Opris1, Catalina Monica Pena1
Organizations/Affiliations:
1“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania
Main Contact Person's Name:
Gianina Ioana Constantin
Main Contact Person's E-Mail:
gianina_constantin@yahoo.com
#0066
Renoprotective Effect Of Celastrol In Diabetic Nephropathy In Rats: Implication Of Mirna-192-5p, Mirna-21-5P, And Autophagy Activation
Author/s:
Samar. M. Al-Tantawy*1, Salma. M. Eraky1, Laila. A. Eissa*1
Organizations/Affiliations:
1 Biochemistry Department, Faculty of Pharmacy, Mansoura University,35516, Egypt.
Main Contact Person's Name:
laila A Eissa
Main Contact Person's E-Mail:
Lailaeissa2002@yahoo.com
#0067
The Relationship Between Hypertension and Thoracic Spine Bone Mineral Density: The Multi-Ethnic Study of Atherosclerosis (MESA)
Author/s:
Ahmed K Ghanem, MD; Venkat S. Manubolu, MD, MPH; April Kinninger, MPH; Robyn L. McClelland, PhD; Jaewon Lim MS; Denise Javier, MD; Khadije.Ahmad, MD; Hossein Hamidi, MD; Marziyeh Bagheri, Mina Deljavanghodrati, MD; MD; Matthew J Budoff MD.
Organizations/Affiliations:
The Lundquist institute at Harbor-UCLA.
Main Contact Person's Name:
Ahmed Ghanem
Main Contact Person's E-Mail:
ahmed.ghanem@lundquist.org
#0068
Patients Admitted With Diabetic Ketoacidosis And A History Of Non-Alcoholic Fatty Liver Disease Have Greater Risk Of Mortality And Worse Clinical Outcomes
Author/s:
Kenan Rahima MD, Trihealth, Mohamad Hijazi MD, Trihealth, Mhd Kutaiba Albuni MD, Trihealth, Amin Eshghabadi MD, Trihealth, Leonid Khoklov MD, Trihealth, Tochukwu Ikpeze MD, Trihealth
Organizations/Affiliations:
Good Samaritan Hospital, Trihealth
Main Contact Person's Name:
Kenan Rahima
Main Contact Person's E-Mail:
mkenan_rahima@trihealth.com
#0069
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study
Author/s:
MOHAMMAD AMIN ESHGHABADI MD, KENAN RAHIMA MD, MUAYYAD ALZAMARA MD, MOHAMAD HIJAZI MD
Organizations/Affiliations:
GOOD SAMARITAN HOSPITAL, TRIHEALTH
Main Contact Person's Name:
MOHAMMAD AMIN ESHGHABADI
Main Contact Person's E-Mail:
MOHDAMIN_AMIN@YAHOO.COM
#0070
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease
Author/s:
Kenan Rahima MD, Trihealth, Fayaz Khan MD, Trihealth, Mohamad Hijazi MD, Trihealth, Mhd Kutaiba Albuni MD, Trihealth, Amin Eshghabadi MD, Trihealth, Leonid Khoklov MD, Trihealth, Tochukwu Ikpeze MD, Trihealth
Organizations/Affiliations:
Good Samaritan Hospital, Trihealth
Main Contact Person's Name
Fayaz Khan
Main Contact Person's E-Mail
Fayaz_khan@trihealth.com
#0071
FIGARO-BM, a Biomarker Study of FIGARO-DKD, Reveals New Insights Into the Mode-of-Action of Finerenone
Author/s:
Mario Berger, PhD,1; Tram Knecht, PharmD,2; Lydia Christopher, BSc,3; Laura Goea, PhD,1; Peter Kolkhof, PhD,1; Aidan MacNamara, PhD,1; Richard Nkulikiyinka, MD,1; Andrea Scalise, MD,4; Adam Skubala, PhD,1; Sebastian Voss, PhD,5; Katja Rohwedder, MD,6; Joachim H. Ix, MD,7; Faiez Zannad, MD, PhD,8; Peter Rossing, MD, DMSc,9; Hiddo J. L. Heerspink, PhD,10
Organizations/Affiliations:
1. Bayer AG, Pharmaceuticals, R&D, Wuppertal/Berlin, Germany; 2. Bayer US LLC, Cardiovascular and Renal United States Medical Affairs, Whippany, New Jersey, USA; 3. Bayer UK, Cardiology, Reading, UK; 4. Bayer Hispania SL, Pharmaceutical Development, Barcelona, Spain; 5. CHRESTOS Concept GmbH & Co. KG, Essen, Germany; 6. Bayer AG, Pharmaceuticals, Medical Affairs, Berlin, Germany; 7. UCSD, Department of Medicine, San Diego, California, USA; 8. Université de Lorraine, Nancy, France; 9. Steno Diabetes Center Copenhagen, Herlev, and University of Copenhagen, Copenhagen, Denmark; 10. University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands
Main Contact Person's Name:
Tram Knecht
Main Contact Person's E-Mail:
tram.knecht@bayer.com
#0072
0072 Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Diuretic Use: A FIDELITY Analysis
Author/s:
Robert J. Mentz, MD,1; Stefan D. Anker, MD,2 Bertram Pitt, MD,3; Peter Rossing, MD DMSc,4,5; Luis M. Ruilope, MD,6-8; Martin Gebel, PhD,9; Peter Kolkhof, PhD,10; Robert Lawatscheck, MD,11; Katja Rohwedder, MD,12; George L. Bakris, MD,13; Asia Quan, PharmD,14; on behalf of the FIDELIO-DKD and FIGARO-DKD Investigators
Organizations/Affiliations:
1. Department of Medicine, Duke University School of Medicine, Durham, NC, USA; 2. Department of Cardiology (CVK) of German Heart Center Charité and Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin, Berlin, Germany; 3. Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA; 4. Steno Diabetes Center Copenhagen, Herlev, Denmark; 5. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; 6. Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain; 7. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain; 8. Faculty of Sport Sciences, European University of Madrid, Madrid, Spain; 9. Statistics & Data Insights, Bayer AG, Wuppertal, Germany; 10. Research & Early Development, Bayer AG, Wuppertal, Germany; 11. Clinical Research, Bayer AG, Berlin, Germany; 12. Medical Affairs, Bayer AG, Berlin, Germany; 13. Department of Medicine, University of Chicago Medicine, Chicago, IL, USA; 14. Cardiorenal Medical Affairs, Bayer US LLC, Whippany, NJ, USA
Main Contact Person's Name:
Asia Quan
Main Contact Person's E-Mail:
asia.quan@bayer.com
#0064
Relationship between myeloperoxidase and metabolic syndrome at older patients
Author(S):
Gianina Ioana Constantin1, Simona Opris1, Catalina Monica Pena1
Organization/Affiliation:
1“Ana Aslan” National Institute of Gerontology and Geriatrics, Bucharest, Romania
Email Contact:
gianina_constantin@yahoo.com
#0073
Pegozafermin, A FGF21 Analog, For The Treatment Of Non-Alcoholic Steatohepatitis (NASH) Patients With F2/F3 Fibrosis
Author/s:
Deepak L Bhatt, MD, MPH; Arun J Sanyal, MD; Stephen A Harrison, MD; Mildred D Gottwald, PharmD; Shibao Feng, PHD; Germaine D Agollah, PHD; Cynthia L Hartsfield, PHD; Hank Mansbach, MD; Maya Margalit, MD; and Rohit Loomba, MD, MHSc
Organizations/Affiliations:
Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York (D.L.B.); Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond (A.J.S.); Pinnacle Clinical Research, San Antonio, TX (S.A.H.); 89bio, San Francisco (M.D.G., S.F., G.D.A., C.L.H., H.M.); 89bio, Rehovot, Israel (M.M.); and the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.)
Main Contact Person's Name:
Cindy Hartsfield
Main Contact Person's E-Mail:
cindy.hartsfield@89bio.com
#0074
Pegozafermin Added To Background GLP-1 Therapy Led To Greater Improvement In Non-Invasive Markers Of Liver Fat, Injury And Fibrosis As Well As Glycemic Control In NASH Patients With F2/F3 Fibrosis At 24 Weeks: A Posthoc Analysis From ENLIVEN
Author/s:
Rohit Loomba, M.D., M.H.Sc., Arun J. Sanyal, M.D., Mildred D. Gottwald, Pharm.D., Shibao Feng, Ph.D., Leo Tseng, Ph.D., Cynthia L. Hartsfield, Ph.D., Hank Mansbach, M.D., Maya Margalit, M.D. and Deepak L. Bhatt, M.D., M.P.H.
Organizations/Affiliations:
NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.); Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University, Richmond (A.J.S.); 89bio, San Francisco (M.D.G., S.F., L.T., C.L.H., H.M.); 89bio, Rehovot, Israel (M.M.); and Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York (D.L.B.)
Main Contact Person's Name:
Cindy Hartsfield, PHD
Main Contact Person's E-Mail
cindy.hartsfield@89bio.com
#0075
Association Between G308A Polymorphism Of TNF-Α Gene And TNF-Α Levels, Insulin Resistance And Histological Alterations In Patients With NAFLD
Author/s:
Yethindra Vityala1; Mahesh Palagudi2; Sneha Para3; Ravi Babu Kamma4; Pavithra Kotha4; Shravani Divity5, Tugolbai Tagaev6
Organizations/Affiliations:
1AJ Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India; 2P.E.S. Institute of Medical Sciences and Research, Kuppam, Andhra Pradesh, India; 3Maheshwara Medical College and Hospital, Hyderabad, Telangana, India; 4SVS Medical College, Mahabubnagar, Telangana, India; 5Government Medical College, Mahabubnagar, Telangana, India; 6I.K. Akhunbaev Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan
Main Contact Person's Name
Yethindra Vityala
Main Contact Person's E-Mail:
yethindravityala10@gmail.com
#0076
The Connection Between Diabetic Kidney Disease And Heart Failure In Individuals With Type 2 Diabetes Mellitus
Author/s:
Rebrova Y, PhD Saienko Y, PhD Marushko Y, Ph.D Professor Mankovsky B
Organizations/Affiliations:
Ukrainian Children’s Cardiac Center, Kyiv, Ukraine
Main Contact Person's Name:
Rebrova Yanina
Main Contact Person's E-Mail:
yaninarebr@gmail.com
#0077
Single-dose GLP-1-based Pancreatic Gene Therapy Maintains Weight Loss After Semaglutide Withdrawal in a Murine Model of Obesity
Author(S):
Alice Liou Fitzpatrick, Suya Wang, Emily Cozzi, Randy Seeley, Jay Caplan, Timothy Kieffer, Harith Rajagopalan
Organization/Affiliation:
Fractyl Health, Inc.
Main Contact Person's Name:
Joseph Giaconia
Main Contact Person's E-Mail:
jgiaconia@fractyl.com
#0078
Effect Of SGLT-2 Inhibitor, Dapagliflozin, On Glycemic Variability In Patients With Reduced Left Ventricular Ejection Fraction Without Diabetes.
Author/s:
Ivanna V. Zubovych, Yanina A. Saienko, Yevhen Yu. Marushko, Borys M. Mankovsky
Organizations/Affiliations:
Ukrainian Children’s Cardiac Center, Kyiv, Ukraine
Main Contact Person's Name:
Ivanna Zubovych
Main Contact Person's E-Mail:
ivannavitalivna1@gmail.com
#0079
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients
Author/s:
HT Pretorius M.D.,Ph.D., NM Bodnar CNMT, B Murray, BM Brosal, D Menke AA
Organizations/Affiliations:
Blue Ash Nuclear Medicine LLC
Main Contact Person's Name:
Harold Pretorius
Main Contact Person's E-Mail
htpetorius@msn.com
#0080
Association Of EDARV370A With Glycemic Traits In Latinos Residing In The Southwest
Author/s:
Carrie S. Standage-Beier, M.P.H., R.D.N., Yann C. Klimentidis, Ph.D., Luis A. Garcia, B.S., Oscar D. Parra, M.P.H., Lisa Soltani, M.D., Eleanna De Filippis, M.D./Ph.D., Gabriel Q. Shaibi, Ph.D., Douglas J. Spegman, M.D., Lawrence J. Mandarino, Ph.D., Dawn K. Coletta, Ph.D.
Organizations/Affiliations:
Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, Arizona, USA
Main Contact Person's Name:
Dawn K. Coletta, Ph.D.
Main Contact Person's E-Mail:
dcoletta@arizona.edu
#0083
The LS-IM Score And Its Relation To Direct Measurements Of Insulin Resistance
Author/s:
Charles M. Rowland (1), Fahim Abbasi (2), Michael J. McPhaul (1)
Organizations/Affiliations:
(1) Quest Diagnostics Nichols Institute, San Juan Capistrano, CA 92675, (2) Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California 94305
Main Contact Person's Name:
Michael J. McPhaul, MD
Main Contact Person's E-Mail:
michael.j.mcphaul@questdiagnostics.com
#0084
The Impact of Processing Methods on Free Fatty Acids Measurements in Type 2 Diabetes
Author(S)
Abigail Epstein, Medical Student¹*, Raquel Poliwoda, RN¹*, Welbeck Sowah, MA¹, Minka Chikolareva, RN, MS, MBA¹, Oana Sandu, MD¹, *First Author, ¹Albert Einstein College of Medicine, Bronx, NY
Organization/Affiliation
¹Albert Einstein College of Medicine
Main Contact Person's Name:
Oana Sandu
Main Contact Person's E-Mail:
oana.sandu@einsteinmed.edu
#0085
NP 0085 Time-Restricted Eating And Its Impact On Weight Loss, Adipose Tissue Distribution, Lean Mass And Blood Pressure In Women With Cardiometabolic Risk Factors
Author/s:
Vanesa Ivana Rayón Gutiérrez1, RD; Diego Emiliano Chávez Fernández1, RD; Jalil López Orozco1, RD, MSc; Eliud Salvador Aguilar Barrera1,2, RD, MSc.
Organizations/Affiliations:
1Posgraduate Department, CICS-UMA, Instituto Politécnico Nacional. Mexico City, Mexico. 2Asociacion Mexicana para el Estudio de la Diabetes y sus Complicaciones, Mexico City, Mexico.
Main Contact Person's Name:
Eliud Salvador Aguilar Barrera
Main Contact Person's E-Mail:
aguilarbarrerae@gmail.com
#0086
Characterization Of Tirzepatide-Treated Patients Achieving Hba1c <5.7% In The SURPASS 1-4 Trials
Author/s:
Julio Rosenstock1, Stefano Del Prato2, Denise Reis Franco3, Luis Vázquez4, Biyue Dai5, Govinda Weerakkody5, Laura Fernández-Landó5, Angel Rodríguez5, Brandon K Bergman5, Xi Chen (Non-author presenter)5
Organizations/Affiliations:
1 Velocity Clinical Research at Medical City, Dallas, TX; 2 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; 3 CPCLIN, Clinical Research Center, Sao Paulo, Brazil; 4 Hospital Marqués de Valdecilla, Santander, Spain; 5 Eli Lilly and Company, Indianapolis, IN, USA
Main Contact Person's Name:
Faustina Jayaprakash
Main Contact Person's E-Mail:
Lilly_Encore_Publications@lilly.com
#0087
Tirzepatide Improved Markers of Islet Cell Function (Fasting Glucagon and HOMA2-B) and Insulin Sensitivity (Fasting Insulin and HOMA2-IR) Compared to Semaglutide in People with Type 2 Diabetes
Author/s:
Katelyn Brown1, Laura Fernandez Landó1, Brandon Bergman1, Melissa K. Thomas1, Bing Liu1, Clare Lee1, Amanda M. Giebel (Non-author Presenter)1
Organizations/Affiliations:
1Eli Lilly and Company, Indianapolis, IN, USA
Main Contact Person's Name:
Faustina Jayaprakash
Main Contact Person's E-Mail:
Lilly_Encore_Publications@lilly.com
#0088
BMF-219: A Novel Therapeutic Agent To Reestablish Functional Beta Cells And Provide Long-Term Glycemic Control
Author/s:
Juan P. Frias, MD, Sanchita Mourya, MD, Brian Munneke, PhD, Mini Balakrishnan, PhD, Priyanka Somanath, PhD, Thomas Butler, MS, MBA
Organizations/Affiliations:
Biomea Fusion
Main Contact Person's Name:
Juan P. Frias
Main Contact Person's E-Mail:
jfrias@biomeafusion.com
#0089
Efficacy Of Ayurveda Based Panchakarma Therapy And Diet Treatment To Reduce Down The Dependency Of OHA In Type 2 Diabetes: An Observational Study
Author/s:
1. Dr Sachin Patil- MD Panchakarm-Regional Head 2. Dr Suvarna Pol - MD Panchakarma -Clinic Head 3. Dr Madhumati Sapkar- BAMS -Clinic Head 4.Dr Nilesh Kulthe- MD kay chikitsa -Zonal Medical Head 5.Dr Sai Patil-MD Samhita - Clinic Head
Organizations/Affiliations:
Vaidya Sane Ayurved Laboratories Limited
Main Contact Person's Name:
Dr. Sachin Patil
Main Contact Person's E-Mail:
dr.sachinpatil@madhavbaug.com
#0091
Effectiveness And Safety Of An Adjuvant Phytoformula In The Treatment Of Patients With Type 2 Diabetes Mellitus.y Of Ayurveda Based Panchakarma Therapy And Diet Treatment To Reduce Down The Dependency Of OHA In Type 2 Diabetes: An Observational Study
Author/s:
Nidia Angélica García Espinoza, DACM (1), Hugo Morales Tello, DACM (1), Ricardo Sacchi Córdova, BS (1), Nicasio Morales Sarabia, BS (1), Jair Isaí Ortega Gaxiola, PhD (1), José Alfredo Primelles Gingele, BS (1), María Magdalena Valencia Gutiérrez, MD, MPH (2), Erick Ayala Calvillo, PhD (3), *Cesar Ochoa Martinez, MD, PhD (4).
Organizations/Affiliations:
(1) SAPI de C.V. – División Elevate® (2) Escuela Superior de Medicina, Instituto Politécnico Nacional, CDMX, México, Especialista en Medicina Familiar IMSS/UNAM. (3) Facultad de Farmacia, Universidad Autónoma del Estado de Morelos. Cuernavaca, Morelos, México. (4) Center for Clinical Research, WesternU Medical Center at Western University of Health Sciences, Pomona, CA, USA.
Main Contact Person's Name:
Cesar Ochoa, MD, PhD
Main Contact Person's E-Mail:
drcochoa@hotmail.com
#0093
Effect Of Tirzepatide On The Progression Of Coronary Atherosclerosis Using MDCT: Rationale And Design Of The Tirzepatide Treatment On Coronary Atherosclerosis Progression (T-PLAQUE)
Author/s:
Hossein Hamidi, MD; Marziyeh Bagheri, MD; Denise A Javier, MD; Ahmed Ghanem, MD; April Kinninger, MPH; Hooman Fazlalizade, MD; Mina Deljavanghodrati, MD; Sajad Hamal; Sina Kianoush, MD; Matthew J. Budoff, MD
Organizations/Affiliations:
The Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Main Contact Person's Name:
Hossein Hamidi
Main Contact Person's E-Mail:
hossein.hamidi@lundquist.org
#0094
Carbohydrate Restriction-Induced Elevations In LDL-Cholesterol And Atherosclerosis: The KETO Trial
Author/s:
Matthew Budoff1, Venkat S. Manubolu1, April Kinninger, Nicholas G. Norwitz, David Feldman, Thomas R. Wood, Ricardo Cury, Theodore Feldman, Jonathan Fialkow, Khurram Nasir
Organizations/Affiliations:
Lundquist Institute
Main Contact Person's Name:
Matthew Budoff
Main Contact Person's E-Mail:
mbudoff@lundquist.org
#0095
Effect Of Sodium-Glucose Transport Protein 2 Inhibitors On All-Cause Mortality In Patients With Gout: A Multi-Center Cohort Study
Author/s:
Shu-Yen Chan MD, MSc, Kevin Sheng-Kai Ma, DDS, PhD
Organizations/Affiliations:
Department of Internal Medicine, Weiss Memorial Hospital/ Uhicago, Chicago, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Main Contact Person's Name:
Shu-Yen Emily Chan
Main Contact Person's E-Mail:
chan0514.eras@gmail.com
#0096
Cardiometabolic Risk Factors in Type 2 Diabetes Persons Evaluated by Continuous Glucose Monitoring
Author/s:
Andreea Morosanu, MD, PHD, Assoc. Prof., Magdalena Morosanu, MD, PHD, Assoc. Prof.
Organizations/Affiliations:
1 Diamed Obesity SRL, Galaţi – Department of Diabetes, Nutrition and Metabolic Diseases, 2 "Dunarea de Jos" University of Galati, Crossborder Faculty
Main Contact Person's Name:
Andreea Morosanu
Main Contact Person's E-Mail
andreeamorosanu17@gmail.com
#0099
Lower Serum Uric Acid Level In Patients With Gout Concurrent Type 2 Diabetes Mellitus Treated With Sodium-Glucose Cotransporter 2 Inhibitors Compared To Dipeptidyl Peptidase-4 Inhibitors: A Population-Based Cohort Study
Author/s:
Shu-Yen Chan MD MSc, Pin-Chia Huang MSc, Kevin Sheng-Kai Ma DDS PhD
Organizations/Affiliations:
Department of Internal Medicine, Weiss Memorial Hospital, Chicago, IL, USA, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA,
Main Contact Person's Name:
Emily Shu-Yen Chan
Main Contact Person's E-Mail
chan0514.eras@gmail.com
#0101
An Assessment Of Demographics And Clinical Outcomes Among Patients With Gestational Diabetes With And Without Diagnosis Of PCOS, Nation-Wide Study
Author/s:
Sindhu Kishore, M.D., Leonid Khokhlov, M.D., Mohammad Hijazi, M.D., Gehna Kishore, M.D., Michael Eerhart, M.D.
Organizations/Affiliations:
Good Samaritan Hospital
Main Contact Person's Name:
Sindhu Kishore
Main Contact Person's E-Mail:
sindhu_kishore@trihealth.com
#0102
Diabetics And Insulin Resistant Patients, Especially Post COVID-19, Have An Increased Biologic Age From Analysis Of Brain FDG PET
Author/s:
HT Pretorius MD,PhD., GM Hubbell MD, B Budke CNMT, NM Bodnar BS,CNMT, B Murray, BM Brosal, D Menke AA.
Organizations/Affiliations:
Blue Ash Nuclear Medicine, LLC
Main Contact Person's Name:
Harold T. Pretorius, M.D., Ph.D.
Main Contact Person's E-Mail:
htpretorius@msn.com
#0103
Pregnants Obesity And Diabetes: A North-African Report
Author/s:
H. Boutrid (MD, PhD), N. Boutrid (MD, PhD), S. Chaat (MD), M. Keghouche (MD), H. Rahmoune (MD), N. Baiben (MDc), A. Baiben (MDc), F. Madaci (MD, PhD)
Organizations/Affiliations:
Faculty o Medicine, University of Setif-1
Main Contact Person's Name
Hakim RAHMOUNE
Main Contact Person's E-Mail
rahmounehakim@gmail.com
#0104
Diabetes Type 1, HLA Genes And Celiac Disease: An Algerian Pediatric Cohort
Author/s:
H. Rahmoune 1.2 (MD), N. Boutrid 1. (MD, PhD), N. Baiben 1 (MDc), A. Baiben 1 (MDc), M. Amrane 1 (MD, PhD)
Organizations/Affiliations:
1: LMCVGN Laboratory, Faculty of Medicine, Sétif-1 University 2: Pediatrics, Setif University Hospital
Main Contact Person's Name:
Hakim RAHMOUNE
Main Contact Person's E-Mail:
rahmounehakim@gmail.com
#0105
Diabetes, Β Cell Apoptosis And The Role Of SIRT2 And Rel/A Nfkb Subunit
Author/s:
Abdemalek Rezgui1 (PhD c), Recha Amel Tachour2(PhD c), Rania Derguine3(PhD c), Anfel Benmesseur 2(PhD c), Fatma Zahra Hab2(PhD c) , Rym Agred1 (PhD), Hakim Rahmoune4 (MD), Nada Boutrid4. (MD, PhD), N. Baiben4 (MD c), A. Baiben4 (MD c), Widad SOBHI1(PhD)
Organizations/Affiliations:
1: Laboratory of Plant Biotechnology and Ethnobotany, Faculty of Nature and Life Sciences, University of Bejaia, 06000, Bejaia, Algeria 2: Research Center of Biotechnology (CRBT), Ali Mendjli, 25000 Constantine, Algeria 3: Laboratory of Applied Biochemistry, Faculty of Nature & Life Sciences, Ferhat Abbas Setif 1 University, Algeria 4: Faculty of Medicine, University of Setif-1, Algeria
Main Contact Person's Name:
Hakim RAHMOUNE
Main Contact Person's E-Mail:
rahmounehakim@mail.com
2022 Accepted Abstracts
Abstracts will be published in the Metabolism Journal
Editor-in-Chief: Christos S. Mantzoros, MD, DSc, PhD h.c. mult.
#0001
Value of Breastfeeding in Pregnant with Gestational Diabetes Mellitus
Abdelghani S.M
#0002
Syringic acid ameliorates experimental diabetic nephropathy in rats through its antiinflammatory, anti-oxidant and anti-fibrotic effects by suppressing Toll like receptor-4 pathway
Omar M. Zabad* 1 , Yara A. Samra1 , Laila A. Eissa* 1
#0004
Non-HDL-cholesterol and atherogenicity in type 2 diabetes mellitus patients
Simona Opriş*, Gianina-Ioana Constantin
#0005
Factors associated with hepatic steatosis in adult Greek subjects with type 2 diabetes mellitus
Angeliki Meritsi, MD1, Emanuel Manesis MD2, Marina Noutsou1 Panagiotis Koussis3, Stamatia Rapti4, Dimitra Latsou5, Ioannis Tsorlalis1, Eustathios Tsitsopoulos4, Hariklia Moshoyianni6, Spilios Manolakopoulos7, Dimitrios Pektasides8, Anastasia Thanopoulou, MD1
#0006
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus.
Angeliki Meritsi, MD1, Dimitra Latsou2, Ioannis Tsorlalis1, Marina Noutsou1, Emanuel Manesis MD3, Ilias Gatos4, Ioannis Theotokas MD4, Pavlos Zoumpoulis MD4, Stamatia Rapti5, Eustathios Tsitsopoulos5, Hariklia Moshoyianni6, Spilios Manolakopoulos MD7, Dimitrios Pektasides MD8, Anastasia Thanopoulou, MD1
#0007
Development of Cardiac specific Neurohormonal based diagnostic marker for Diabetes linked cardiac failure
Iram Murtaza, Iram Mushtaq, Ayesha Ishtiaq
#0008
miRNAs and Endothelin: A potential nexus in the roadmap for diabetes linked cardiac complications therapeutic strategy
Ayesha Ishtiaq, Iram Mushtaq, Iram Murtaza
#0009
FTO, PPAR-γ and ABCC8 gene variation and hypertension as determinants of cardiometabolic risk in CVD patients
Kanwal Rehman1,2,, Sania Niaz2, Ayesha Tahir2, Komal Jabeen1,2, Muhammad Sajid Hamid Akash3
#0010
Insulin resistance susceptibility is associated with BPA exposure
Muhammad Sajid Hamid Akash1, Abdul Qader1, Kanwal Rehman2
#0011
Long-term exposure of Bisphenol A impairs metabolism and develop insulin resistance
Kanwal Rehman1, Abdul Qader2, Muhammad Ejaz ul Haq2, Muhammad Sajid Hamid Akash2
#0012
The use of Rozuvastatin (Rozuvastatin Denk) and Metformin combination in women with abdominal obesity
K.Tchaava, N.Gegeshidze ,M.Shavdia, N.Ninashvili, M.Gogiashvili
#0013
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
WEI SYUN HU
#0014
Role of CHA 2 DS 2-VASc score in predicting new-onset atrial fibrillation in patients with type 2 diabetes mellitus with and without hyperosmolar hyperglycaemic state: real-world data from a nationwide cohort
WEI SYUN HU
#0015
A nationwide cohort study of the role of CHADS 2 score in predicting lower extremity amputation and death among patients with peripheral arterial occlusive disease
WEI SYUN HU
#0016
Diabetes and Cancer. How far off cancer-screening uptake among female diabetic patient?
Noraidatulakma Abdullah1,2, Azmawati Nawi1,3, Mohd Arman Kamaruddin1, Nazihah Jalal1, Rahman Jamal1.
#0017
Demographics of COVID 19 admitted patients and obesity: a retrospective study
Vlachopoulou M., Sarantis N., Chatzis G.
#0018
Sitagliptin on carotid intima-media thickness in type 2 diabetes and hyperuricemia patients: A subgroup analysis of the PROLOGUE study
Yipin Zhao, Zebin Lin, Qingwei Chen
#0019
A review on the role of Phytosterol enriched food in anticancer activity
Anup Ghosal
#0020
Reversing Time: A possibility through chronobiology EFFECT OF TINE RESTRICTED MEAL INTAKE ON ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN TYPE 2 DIABETICS
Dr.Smriti Rastogi1, Dr.Narsingh Verma2
#0021
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease
Dmitry Emelyanov, Nataliya Emelyanova, Tatyana Petrushanko, Valentina Galchinska, Tatyana Bondar, Olena Otchenashenko1
#0022
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study
Kevin Sheng-Kai Ma
#0024
Aldose Reductase inhibition by AT-001 Prevents Diabetic Cardiomyopathy Via Reducing Myocardial Fatty Acid Oxidation Rates
Keshav Gopal1,2, Qutuba G Karwi1, S. Amirhossein Tabatabaei-Dakhili1,2, Cory S. Wagg1, Riccardo Perfetti3, Ravichandran Ramasamy4, John R Ussher1,2, Gary D Lopaschuk1
#0025
Cardio-metabolic factors associated to mortality in patients with COVID-19
Camey Eduardo, M.D., Arauz Guillermo, M.D., Cárcamo Alejandra, M.D, Celis Grecia, M.D.
#0026
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis
James R. Churilla, PhD, MPH, Tammie M. Johnson, DrPH, MPH, Michael R. Richardson, Ph.D., MSH, MS, and Ralph G. Cosentino, MSH
#0027
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models
Ali Haider Bangash*(1),(2)§, Arshiya Fatima(1)§, Saiqa Zehra(1)§, Ali Haider Shah(1)§, Syed Mohammad Mehmood Abbas(1)§, Syed Muhammad Qasim Shah(1)§, Ayesha Khalid(1)§, Hashir Fahim Khawaja(1)§, Adil Baloch(1)¶, Ali Danish Khan(1)¶, Aliya Ali(1)¶, Aymen Yunus(1)¶, Farhan Faisal(1)¶, Gulfam Jameel(1)¶, Kashaf Mushtaq(1)¶, Maryam Naveed Abbasi(1)¶, Mehwish Nawaz(1)¶, Mishal Bilal(1)¶, Muhammad Ashraf(3)¶, Musa Kamil(1)¶, Noor Ayesha*(1)¶, Rabia Mohsin(1)¶, Sadaf Khalid(1)¶, Saleha Yurf Asghar(1)¶, Syeda Tatheer Zahra(4)
#0028
Is coffee a potential appetite suppressant?
M. Sedanur MACİT, Eda KÖKSAL
#0029
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease
Tulio Loyola Correa, Mariana Sandoval Terra Campos Guelli
#0030
Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0031
Adolescence arterial stiffness precedes elevated blood pressure in young adulthood: The ALSPAC birth cohort
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0032
Longitudinal and bi-directional associations of arterial stiffness with general and central fat mass from adolescence through young adulthood: The ALSPAC Study
Andrew O. Agbaje MD, MPH1, Alan R. Barker PhD2, Tomi-Pekka Tuomainen MD, PhD1
#0033
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2
Faisal Ali , Ahmad Al-Junaid, Ali Mohamed Saleh
#0034
BODY WEIGHT CHANGE IN HYPERCOLESTROLEMIC RATS MODEL AFTER INTERVENTION WITH AVOCADO (Persea americana Mill) JUICE
Muhammad Luthfi Adnan1, Raihan Lucky Buana1, Dimas Agus Cholili1, Hilmi Ardian Sudarto1, Amalia Adityas Dyah Safitri1, Tiar Ramadhan1, Miranti Dewi Pramaningtyas1
#0035
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades
Manar Ahmed Kamal 1 , Raneem Mahmoud Al-Arawi 2
#0036
Vitamin D status and its Association with Atherogenic Index of Plasma in Young Subjects with PCOS
Vipan Talwar
#0037
Effects of bariatric surgery versus pharmacological treatment on oxidative stress in metabolic syndrome
Tomas Augusto Castillo1, Micaela Milagros Rossi1, María de la Paz Scribano Parada1, Franco Signorini1,2, Ismael Fonseca3, María del Carmen Baez1.
#0038
The Effect of Diabetes Mellitus and Revascularization Status on Cardiorespiratory Fitness in Multi-vessel Acute Coronary Syndrome Patients
Hye-Su Yun1, Hee-Jung Lee1, Cheol Hyun Lee1, Yun-Kyeong Cho1, Hyuck-Jun Yoon1, Jin-Wook Chung1, Hyungseop Kim1, Chang-Wook Nam1, Seung-Ho Hur1, Jong-Chan Youn2, and In-Cheol Kim1*
#0042
Polymorphism of apolipoprotein E in children with metabolic diseases of the biliary tract
Belousova OYu, D.Med.Sc., Shutova OV, Pavlenko NV, Solodovnichenko IG, Вabadzhanian OM, Voloshyna LG, Hanzii OB, Abbas Kaafarani, Savytska KV, PhD., Kazaryan LV
#0043
Role of SORT1 gene in patients with Coronary Artery Disease.
Shelly aggarwal, Rajiv Narang, Daman Saluja, Kamna Srivastava
#0044
TAS2R38 taste receptor gene and metabolically unhealthy obesity
Aleksandr Abaturov, Anna Nikulina, Dmitriy Nikulin
#0045
Nitrogen oxide metabolism in the liver under conditions of systemic inflammatory response
Mykytenko А.О., Akimov О.Y., Matsytska Y.K., Neporada K.S.
#0046
ASSOCIATIONS BETWEEN PHYSICAL ACTIVITY AND RISK FACTORS FOR TYPE II DIABETES IN PREDIABETIC ADULTS
Rukia Yosuf
#0047
Impact of COVID-19 outbreak in health care of people with type 2 diabetes: evidence from a cross-sectional study in Albania
1 Fatjona Kamberi, 1Jerina Jaho, 3 Enkeleda Sinaj, 3Vjollca Ndreu. 3Ilirjana Zekja
#0048
Psoriasis in childhood and metabolic syndrome : a systematic review
Mariana Sandoval Terra Campos Guelli
#0049
Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters
François Briand(1), Valentin Sencio(2,3), Thierry Sulpice(1) and François Trottein(2,3)
#0050
Alpha-lipoic acid as an alternative treatment for diabetic polyneuropathy ?
DEMMOUCHE abbassia; Bekhadda Hadjer, Menadi Noreddine, Bouazza Sofiane, Mai Hicham
#0051
Effects of metformin and lutheinizing hormone receptor agonists on steroidogenesis and spermatogenesis in rats with type 2 diabetes with their separate and combined administration
A.A. Bakhtyukov, K.V. Derkach, A.M. Stepochkina, V.N. Sorokoumov, L.V. Bayunova, I.A. Lebedev, A.O. Shpakov
#0052
Evaluation of metabolic syndrome, insulin secretion and insulin resistance in adolescents with overweight and obesity
Yethindra Vityala1; Tugolbai Tagaev2; Altynai Zhumabekova3; Sagynali Mamatov4
#0053
Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Severe Hypertriglyceridemia (SHTG) – Initial Baseline data from an Ongoing Phase 2 Study
Deepak L. Bhatt, MD, MPH, John J.P. Kastelein, MD, Teresa Parli, MD, R Will Charlton, MD, Cynthia L Hartsfield, PhD, Shibao Feng, PhD, Hank Mansbach, MD, Harold Bays, MD
#0054
Partial Reversal of T2D Through Dietary Manipulation
LK Shankhdhar, Kshitij Shankhdhar, Smita Shankhdhar
#0055
Co-administration of metformin and intranasal insulin more effectively restores the metabolic and hormonal parameters in diabetic rats in comparison with monotherapy
Anna Mikhailovna Stepochkina, Kira Viktorovna Derkach, Andrey Andreevich Bakhtyukov, Vera Mikhailovna Bondareva, Natalia Evgenievna Basova, Alexander Olegovich Shpakov
#0056
Effect of Remote Ischemic Conditioning in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
Nehal Nasr Mahmoud 1,2’, Fatma Mohamed Sayed 1,2’, Manar Ahmed Kamal 2,2’ Amal suliman alttaira 3,2’ Sarah Makram Elsayed 4,2’, Mais Hutham Sabri 5,2’, Ahmed Alaa AbdelAzim6,2’, Fatma A. Monib7,2’, Sondos Hussien Osman 8,2’, Massara ben ahmeida 8,2’, Maisa Saleh Assiwi 9,2’
#0057
BIO89-100 Demonstrated Robust Reductions in Liver Fat, Improved Metabolic Parameters, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH.
Juan Pablo Frias, MD, Grisell Ortiz-Lasanta, MD, Cynthia L Hartsfield, PhD, Leo Tseng, PhD, R William Charlton, MD, Hank Mansbach, MD, Maya Margalit, MD, Rohit Loomba, MD
#0058
The utility of novel CGM metrics in the LGA newborn prediction in women with type 1 diabetes – assessment of the cut-off values.
Rafal Sibiak1,2, Beata Mrzewka-Rogacz1, Pawel Gutaj1, Urszula Mantaj1, Ewa Wender-Ozegowska1
#0059
Hepatic Steatosis, Fibrosis, and Insulin Resistance: Implications for Therapy
Olga Lavrynenko 1,2, MD, PhD, Muhammad Abdul-Ghani1, MD, PhD , Hector Santos, MD 2andRalph DeFronzo1, MD
#0060
Adolescence arterial stiffness precedes insulin resistance in young adulthood: A 7-year temporal longitudinal findings using cross-lagged structural equation model
Andrew O. Agbaje, MD, MPH1, Alan R. Barker, PhD2, Tomi-Pekka Tuomainen, MD, PhD1
#0061
The association between sialic acid and type 2 diabetes in older patients
Gianina Ioana Constantin1, Catalina Monica Pena1, Simona Opris1
#0062
Fulminant Insulin-Dependent Diabetes in Patient with Squamous Cell Carcinoma on Nivolumab Presenting as Severe Diabetic Ketoacidosis
Nauman A Jadoon, M Adnan Afzal
#0063
Relations between food intake, weight status and cardio-metabolic disturbances in area representative group
Andreea Morosanu, Magdalena Morosanu
#0064
Evaluation of the effect of β-Caryophyllene on oxidative stress in BALB / c mice with streptozotocin-induced diabetes
Paola T. Villalobos-Gutierrez, Maria de Jesus Romero-Hernandez, Oscar Gutierrez Coronado
#0065
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages
Alia Shatanawi 1, Ebaa M. Al Zayadneh 1, Tahira Lemtalsi, Abdelrahman Y. Fouda 2, Ruth B. Caldwell 2, R. William Caldwell 2
#0066
Integration of genetic colocalizations with physiological and pharmacological perturbations identifies cardiometabolic disease genes
Michael J. Gloudemans1,2*, Brunilda Balliu3*, Daniel Nachun4,5, Matthew G. Durrant4, Erik Ingelsson6, Martin Wabitsch7, Thomas Quertermous6,8, Stephen B. Montgomery2,4, Joshua W. Knowles6,8,9, Ivan Carcamo-Orive6,8†
#0067
Recording of the spinal neurovascular response triggered by a non-noxious peripheral nerve stimulation in patients with diabetes mellitus
Juan Esteban Oyarzún1,2, Raul Caulier Cisterna1,2, Juan Pablo González Appelgren1, Antonio Eblen-Zajjur A3; Sergio Uribe1,2,4
#0068
Prevalence trends in obesity defined by the Relative Fat Mass (RFM) index among adults in the United States: 1999−2018
Orison O. Woolcott a,b Till Seuring c
#0069
Diabetes knowledge and associated factors in rural Eastern Cape, South Africa: A cross sectional study
Eyitayo Omolara Owolabi
#0070
Knowledge and practice of foot care and examination among individuals with diabetes in rural Eastern Cape Province, South Africa
Eyitayo O. Owolabi, Kathryn M. Chu
#0071
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review
Mariana Sandoval Terra Campos Guelli, Tulio Loyola Correa, Andreza Brandão da Silva, Carina de Oliveira Lopes, Cristiane Freitas Couto
#0072
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland
Daniel Bałut, Marcin Kleibert, Patrycja Małgorzata Bąk, Jakub Zieliński , Beata Mrozikiewicz-Rakowska
#0073
Evaluation of response to clopidogrel therapy in patients with acute coronary syndrome by platelet aggregation method
Liana Suciu1, Maamoun Rebai2, Maria Suciu1, Valentina Buda3, Hanene Ghozzi Allouche4
#0074
Kallistatin, IL-10, IL-1β and hsCRP in the diagnosis of non-alcoholic fatty disease on the background of hypertension
Anastasiia Rozhdestvenska, PhD student, Natalia Zhelezniakova, MD, D.M.Sc. prof.
#0076
Total Insulin Resistance Index to Risk-Stratify Dysglycemia and Define Pre-Prediabetes
Suresh N. Shinde,MD.; Rituparna S. Shinde; Ashwini S. Joshi
#0077
Scientific evaluation of a folk herbal compound for antihyperglycemic and associated bio health markers in chemically induced diabetic rat model
Haseeb Anwar1, Arslan Iftikhar1, Humaira Muzaffar1, Muhammad Imran2 and Imtiaz Mustafa1
#0078
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease
Guzal Naimovna Sobirova, Zarnigor Orifovna Bafoeva, Mirvasit Mirvasikovich Karimov
#0079
The association between AST/ALT ratio and modified HOMA-IR in participants of the 1993 Pelotas (Brazil) birth cohort
Tulio Loyola Correa, Deise Farias Freitas, Clarice Brinck Brum, Isabel Oliveira de Oliveira
#0080
SACUBITRIL/VALSARTAN TREATMENT MAY BE ASSOCIATED WITH IMPROVED FRONTAL PLANE QRS-T ANGLE AND CARDIAC REPOLARIZATION PARAMETERS.
Mevlut Serdar Kuyumcu, MD1, Sebahat Ulusan3, Mehmet Hakan Uzun, MD2, Bayram Ali Uysal, MD1, Fatih Aksoy, MD1, Ercan Varol, MD1
#0081
Moringa oleifera, Lam. Extract as Therapy for Insulin Resistance Through Increasing Insulin and GLUT-2 Expression in Pancreatic Islet Cells of Metabolic Syndrome Rats Model
Siti Zahra Afifah, Sutan Kahfi Alif Widianto, Indah Ariesta
#0082
Features of myocardial damage indexes in patients with metabolic syndrome and nonalcoholic fatty liver disease
Guzal Sobirova, Jamol Uzokov, Zarnigor Bafoeva, Mirvasit Karimov
#0083
The exoWAT, endoWAT and ectoWAT Dictate Dysmetabolism, Dyslipidemia and Diabetes
Suresh N. Shinde,MD.
#0084
Improvement of hyperglycemia in a diabetic gastric cancer patient after total gastrectomy. A case report.
1- Karam R. Motawea , 2- Nancy Ibrahim
#0085
The Next-generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery From Hypoglycemia Across Subgroups
Tadej Battelino1; Timothy Bailey2; Ramin Tehranchi3, Leslie Klaff4, Thomas R Pieber5, Ulrike Hövelman6, Leona Plum-Mörschel6,7, Anita E Melgaard3, Ronnie Aronson8, Linda A DiMeglio9; Thomas Danne10, and David Kendall3
#0086
Predicting True Time to Recovery From Insulin-induced Hypoglycemia With Dasiglucagon
Tadej Battelino1; Timothy Bailey2; Ramin Tehranchi3; Leslie Klaff4; Thomas R Pieber5; Ulrike Hövelmann6; Leona Plum-Mörschel6,7; Anita E Melgaard3; Ronnie Aronson8; Linda A DiMeglio9; Thomas Danne10; Anne Peters11; and David Kendall3
#0087
Steatosis in chronic hepatitis B and its impact on the therapeutic response to entecavir
Hana Chaabouni, Ichrak Bougharriou, Nabil Lachiheb, Khouloud Mnif, Tarak Ben Jemaa, Khaoula Rekik, Fatma Smaoui, Makram Koubaa, Chakib Marrakchi, Boussayma Hammami, Mounir Ben Jemaa
#0088
The impact of chronic kidney disease in diabetic COVID-19 patients
Hana Chaabouni, Ichrak Bougharriou, Khouloud Mnif, Majdi Maazoun, Tarak Ben Jemaa, Khaoula Rekik, Fatma Smaoui, Makram Koubaa, Chakib Marrakchi, Boussayma Hammami, Mounir Ben Jemaa
#0089
Are we able to adequately predict diabetes remission after metabolic surgery?
Izabela Karpińska1, Joanna Choma1, Michał Wysocki2, Alicja Dudek1, Piotr Małczak1, Magdalena Szopa3, Michał Pędziwiatr1, Piotr Major1
#0090
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging
Jesús-Aureliano Robles-De Anda, Fernanda-Isadora Corona-Meraz, Perla-Monserrat Madrigal-Ruíz, Jorge Castro-Albarran, Miltón-Omar Guzman-Ornelas, Jaqueline-Alejandra Noboa-Velasteguic, Ana-Lilia Fletes-Rayas and *Rosa-Elena Navarro-Hernández
#0091
Association between diabetes and IgM antibodies against endogenous gonadotropin-releasing hormone in serum. A meta-analysis.
1- Karam R. Motawea , 2- Nancy Ibrahim
#0092
Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians
Dr. Alka Gandhi1, Dr. C R Anand Moses2, Dr. Nilesh Detroja3, Dr. Ajay Ajmani4, Dr. Mahesh Abhyankar5, Dr. Silki5
#0093
Patient perspectives and experiences of basal insulin (BI) titration in type 2 diabetes (T2D): A US cross-sectional survey
Stewart Harris(1), Kamel Mohammedi(2), Monica Bertolini(3), John White(4), Maureen Carlyle(4), Fang Liz Zhou(3), John Anderson(5), Jochen Seufert(6)
#0094
Biological potential of tricetin on diabetes disease: An Pharmacological approaches in the medicine through scientific data analysis
Dinesh Kumar Patel, Kanika Patel
#0095
Biological potential of cirsimaritin against diabetes mellitus: Medicinal importance and therapeutic benefit
Dinesh Kumar Patel, Kanika Patel
#0096
Biological potential and antioxidant activity of strictinin in the medicine through literature data analysis
Dinesh Kumar Patel, Kanika Patel
#0097
Biological potential and antioxidant activity of irisolidone in the medicine through scientific data analysis
Dinesh Kumar Patel, Kanika Patel
#0098
Therapeutic importance of eriodictyol in the medicine for the treatment of diabetes and associated complication through its insulin secretagogue properties
Dinesh Kumar Patel, Kanika Patel
#0099
Biological importance of prunin in the medicine for the treatment of diabetes related complication: Therapeutic benefit through data analysis
Dinesh Kumar Patel, Kanika Patel
#0100
Biological effect of ginkgetin on kidney injury: Health benefit in the medicine through scientific data analysis
Dinesh Kumar Patel, Kanika Patel
#0102
Anti-atherosclerosis activity of meranzin hydrate in the medicine: Therapeutic benefit through scientific data analysis
Dinesh Kumar Patel, Kanika Patel
#0103
Biological effect of nicotiflorin against acute myocardial Infarction: Therapeutic role in the medicine through scientific data analysis
Dinesh Kumar Patel, Kanika Patel
#0106
Compensatory Hyperinsulinemia is a Hidden Risk Factor for Type 2 Diabetes: CARDIA 30-year Follow Up
David P. Cistola, M.D., Ph.D. and Alok K. Dwivedi, Ph.D.
#0107
Postprandial hyperglucagonemia accompanies morbid obesity even in non-diabetic patients
E.A. Shestakova, I.A. Sklyanik, A.S. Panevina, L.V. Nikankina, M.V. Shestakova, I.I. Dedov
#0108
COVID-19 related morbidity and mortality among patients with diabetes
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
#0109
Challenges of diabetes management during COVID-19 infection
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
#0110
Pyogenic spondylodiscitis in diabetics
H. Chaabouni, F. Smaoui, M.Maazoun, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
#0111
COVID-19 and metabolic syndrome
H. Chaabouni, F. Smaoui, K. Mnif, K. Rekik, C. Marrakchi, M. Koubaa, M. Ben Jemaa
#0113
Analysis of predictors affecting the primary endpoint in patients with ischemic etiology chronic heart failure in combination with prediabetes
B.T.Kurmanbekova, A.M.Noruzbaeva, A.R.Rustambekova, A.I.Moldomamatova
#0114
Biological effect of nicotiflorin against hepatic complication through literature data analysis of various scientific research works
Dinesh Kumar Patel, Kanika Patel
#0115
Therapeutic effect of eriocitrin on osteoarthritis: An update through literature data analysis
Dinesh Kumar Patel, Kanika Patel
#0116
Anti-inflammatory activity of corylin in the medicine: Biological importance through scientific data analysis
Dinesh Kumar Patel
#0117
Biological importance and therapeutic benefit of sciadopitysin on Myocardial infarction: Biological application of creatine kinase and lactate dehydrogenase in the medicine
Dinesh Kumar Patel
#0118
Biological importance of cirsiliol on xanthine oxidase for the treatment of renal disorders: Medicinal uses and therapeutic importance
Dinesh Kumar Patel
#0119
Diabetic foot osteitis: more than double trouble
K.Mnif, F.Smaoui, H.Chaabouni, K.Rekik, I.Boughariou, M.Koubaa, M.Ben Jemaa
#0120
TyG index correlation with surrogate measures of visceral obesity, insulin resistance and non-alcoholic fatty liver disease
Csép Katalin*, Bálint Ágnes**
#0121
Diabetes mellitus and infection: lower limbs skin and soft tissue infection
K.Mnif, F.Smaoui, H.Chaabouni, K.Rekik, I.Boughariou, M.Koubaa, M.Ben Jemaa
#0122
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multicenter, randomized, open-label, controlled clinical trial
Jun Yao,1 Damei Wang,2 Xiaohui Guo,1
#0123
Association between hypertension and severity of NAFLD among adults with obesity
Diego Chambergo-Michilot, Mariella R. Huaman, Paola K. Rodrigo-Gallardo, Angie Z. Vasquez-Chavesta, Gustavo Salinas-Sedo, Carlos J. Toro-Huamanchumo
#0124
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey
Maria Suciu1, Oumaima Makni2, Liana Suciu1, Valentina Oana Buda1, Lavinia Vlaia1, Vicențiu Vlaia1, Carmen Cristescu1
#0125
Breastfeeding to Prevent Kawasaki Disease: a not-to-miss opportunity !
Nada BOUTRID, Hakim RAHMOUNE
#0126
Epidemiological study on short and long-term weight loss with improvement of metabolic control in obese diabetic patients with a standardized multidisciplinary weight loss program (DIAMEX Study).
Francisco J. Nachón¹, MD, MSc., PhD, FACS, Etzel Cruz Cruz², RD, MPH, Ignacio Sajoux³, MD, Cesar Ochoa⁴, MD, PhD.
#0127
Type 1 Diabetes & Related Autoimmune Disorders
Nada Boutrid 1,2 , Hakim Rahmoune 1,2, Hafida Cherif 2, Belkacem Bioud 1,2
#0128
Importance of Each Hour Glucose Measurement During Oral Glucose Tolerance Test and Correlation with Insulin Secretion
T. Totomirova, M. Arnaudova
#0129
Compensated hypogonadism and erectile dysfunction in type 2 diabetes (n=120)
H. Marmouch, H. Jenzri, I. Khochtali.
#0130
Multiple Autoimmune Syndromes in Type 1 Diabetes
Nada Boutrid (1,2), Hakim Rahmoune (1,2), Hafida Cherif (1,2), Belkacem Bioud (1,2)
#0131
Stress urinary incontinence and genital prolapse are associated with massive obesity in Tunisian women (n=58)
H. Marmouch, Soumaya Tahri, Ines Charrad, Ines Khochtali.
#0132
Interaction between Metabolic syndrome, insulin resistance and oxidative stress in hypertensive patients
OTMANE.A, KASDI.F, IBOUCHRITEN.N, MAKRELOUF.M, ZENATI.A
#0133
Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic
Hala Boutrid (1), Nada Boutrid (2,3), S. Chaat (1), M. Keghouche (1), H. Rahmoune (2,3), F. Madaci (1)
#0134
High Prevalence of Compensatory Hyperinsulinemia in U.S. Teenagers: The 2015-2018 National Health and Nutrition Examination Survey (NHANES)
India Bradley, B.S., Alok K. Dwivedi, Ph.D., David P. Cistola, M.D., Ph.D.
#0135
Diagnostic performance of the GGTP/HDL-C ratio for NAFLD in adults with obesity candidates for bariatric surgery
Renzo Pajuelo-Vasquez1, Victoria Durango-Chavez2, Jerry K. Benites-Meza3, Carlos J. Toro-Huamanchumo4
#0136
FIBROSCAN IN ASSOCIATION WITH FIB-4, APRI, AND AST/ALT RATIO FOR ASSESSMENT OF LIVER FIBROSIS IN NON ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH T2DM
Dr Dakshata Padhye, Dr Snehal Tanna, Ms Aleyamma James, Ms Nithya Nair, Ms Muskan Shah, Ms Reva Kovil
#0137
Continuous Glucose Monitoring and Glycemic Control in People With Type 2 Diabetes: Real-World Study.
Alondra Nicole Maldonado Reyes1, Arely Joseline Lugo de la Cruz1, Cecilia Nohemí Ramírez Frias1, Martha Evelyn Mirafuentes Ríos1, Eliud Salvador Aguilar Barrera1,2
#0138
Carbohydrate consumption, insulin use and glucose monitoring knowledge in people with type 1 diabetes.
Alondra Nicole Maldonado Reyes1, Cecilia Nohemí Ramírez Frias1 , Arely Joseline Lugo de la Cruz1, Alberto Isaí Martínez López1, Eliud Salvador Aguilar Barrera1,2
#0139
Role Of Diabetes and Hypertension in The Vascular Complications of The Extremities with Tissue Pattern Modifications and Their Role in Atherothrombotic Disease – A Histomorphometric Analysis
VENUMADHAV NELLURI1, Dr. RAMESH RAO T. 2, SUDARSHAN S.1, DEEPTHINATH R.1
#0140
T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study
Abdelgani S, Abdul-Ghani T, Puckett C, Migahid O, Migahed A, Adams J, Triplitt C, DeFronzo RA, Jayyousi A, Abdul-Ghani M
#0141
Overweight is Not a Diabetes Risk Factor for Insulin-sensitive Individuals: CARDIA 30-year Follow Up
David P. Cistola, M.D., Ph.D., Alok K. Dwivedi, Ph.D.
#0142
Features of Ultrastructural Changes in Type II Alveolocytes in Young Rats On the Background of Chronic Hyperglycemia
Abdul-Rahman Toufik, Wireko Andrew Awuah, Teslyk T.P.
#0143
Association of TCF7L2 gene polymorphisms with T2DM in the population of Pakistan
Maliha Sarfraz
#0144
EFFECT OF ADMINISTRATION OF AVOCADO JUICE (PERSEA AMERICANA MILL) ON RAT-INDUCED MALONDIALDEHID (RATTUS NORVEGICUS) LEVELS
Kahinta Putri Ardina, Miranti Dewi Pramaningtyas, Asri Hendrawati, Luthfi Adnan,Hilmi Adrian, Dimas Agus, Gusta Nariski, Raihan Lucky
#0145
Maternal weight gain associated with vitamin D deficiency and treatment outcome
Nino Abesadze
#0146
Autoimmune pancreatitis and its relevance
Mariana Sandoval Terra Campos Guelli, Daniela Bastos de Almeida Zampier, Lorena Araujo Silva Dias, Júlia Pereira de Melo Oliveira; Lucas Montenegro de Souza
#0147
ASSOCIATION OF ENDOCAN LEVEL AND OBESITY WITH THE DEVELOPMENT OF CARDIOVASCULAR EVENTS
B. Baidildina, L. Turgunova, A. Turmukhambetova, Y. Laryushina.
#0148
Omentin-1 levels are related with cardiac remodeling in patients with hypertension and type 2 diabetes
Oleksii Korzh, Yana Fylenko, Sergiy Krasnokutskiy
#0151
Obesity, overweight, elevated waist circumference and Insulin differ in their associations with insulin resistance markers- the ERICA study
Rodolfo Deusdará 1,2, Amanda de Moura Souza 2, Moyses Szklo 3
#0152
Exploring interactions among clustered components of Metabolic Syndrome with diabetes and prediabetes in The Study of Cardiovascular Risk Factors in Adolescents – ERICA Study
Rodolfo Deusdará1,2, Amanda de Moura Souza2, Moyses Szklo3
#0153
New onset Diabetes Mellitus in a COVID-19 patient: A Case report.
Karam R. Motawea1, Kirellos Said Abbas1, Yossef Hassan AbdelQadir1, Fatma A. Monib2
#0154
Elucidation of early markers in Insulin resistance Diabetes patients of Kashmir Valley.
Haamid Bashir1*, Mohammad Hayat Bhat2 , Sabhiya Majid1 , Rabia Hamid3
#0155
Glycemic Control with Improvement in HOMA2 IR and HOMA2 Beta: Impact of Digital Twin Enabled Precision Nutrition for Remission of Diabetes
Paramesh Shamanna [1], Shashank Joshi [2], L.isa Shah [3], Mala Dharmalingam [4], Arun Vadavi [5], Suresh Damodaran [6], Jahangir Mohammed [3], Maluk Mohamed [1], Terrence Poon [3], Ashok Keshavamurthy [1] ,Thajudeen Mohamed [1], Suchitra Bhonsley [1 ]
#0157
Anti-hyperglycemic and hepato-protective effects of thymoquinone (Nigella sativa oil) in diabetes
Widad Sobhi 1,2, Nada Boutrid 3, Abdelmalek Rezgui 2, Hakim Rahmoune 3, Yacine Benguerba 4
#0158
Correlation between lifestyles assessed with the FANTASTIC questionnaire and cardiovascular risk in workers of a Peruvian hospital
Sheylla T. Céspedes-Ramírez, Sefora N. Anglas-Lopez, Anderson N. Soriano, Salomón Huancahuire Vega
#0159
Comparison of three indexes HOMA, QUICKI and TyG to evaluate insulin resistance in type 2 diabetic patients.
Amel OTMANE, Sadjia ACID, Fahima ALLANE ,Mohamed MAKRELOUF , Akila ZENATI
#0160
Metabolic syndrome as a risk factor for peripheral arterial disease: a systematic review and meta-analysis
Jared Fernandez-Morales, Sebastian Medina-Ramirez, David R. Soriano-Moreno, Abdiel H. Coico-Lama, Anderson N. Soriano, Jessica Hanae Zafra-Tanaka
#0161
Copeptin and metabolic syndrome: a systematic review
Brenda Galindo-Yllu, Ricardo Rojas-Humpire, David R. Soriano-Moreno, Jessica Hanae Zafra-Tanaka
#0162
Real-world outcomes in people with type 2 diabetes (PWD2) and renal impairment receiving insulin glargine 300 U/mL (Gla-300) and insulin degludec 100U/mL or 200U/mL (IDeg): the DELIVER-R study
Timothy Bailey,1 Scott Urquhart,2 Jukka Westerbacka,3 Jasvinder Gill,4 Charlie Nicholls5
#0163
Add (heart) insult to (vascular) injury: Hashimoto and Preeclampsia
H.Boutrid 1 , N.Boutrid 2,3 , M. Merzouk 1 , H. Rahmoune 2,3 , K. Ait Mouhab 3, F.Madaci 1
bottom of page